Skip to main content
Healthcare

STAT+: Roche continues to look to China for new drugs

STAT+: Roche continues to look to China for new drugs

Feed excerpt — reported by STAT News

China's Hansoh Pharmaceutical Group has announced that it struck a massive deal with Roche to develop a portfolio of antibody-drug conjugates.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.